Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
Authors
Keywords
-
Journal
Molecular Therapy-Nucleic Acids
Volume 33, Issue -, Pages 376-390
Publisher
Elsevier BV
Online
2023-07-15
DOI
10.1016/j.omtn.2023.07.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature
- (2022) Wenwei Chen et al. International Journal of Medical Sciences
- Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
- (2022) Giovanni Luca Beretta et al. Cells
- Pan‐Cancer analyses of Necroptosis‐Related genes as a potential target to predict immunotherapeutic outcome
- (2022) Zheng Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense
- (2021) Annelise G. Snyder et al. Annual Review of Immunology
- Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
- (2021) Qianhui Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pyroptosis: a new paradigm of cell death for fighting against cancer
- (2021) Yixin Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PANoptosis in viral infection: The missing puzzle piece in the cell death field
- (2021) Lam Nhat Nguyen et al. JOURNAL OF MOLECULAR BIOLOGY
- AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
- (2021) SangJoon Lee et al. NATURE
- Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
- (2021) Miyad Movassaghi et al. Cancers
- A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma
- (2021) Wenying Zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Apoptosis, Pyroptosis, and Necroptosis—Oh My! The Many Ways a Cell Can Die
- (2021) Natália Ketelut-Carneiro et al. JOURNAL OF MOLECULAR BIOLOGY
- ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
- (2021) Rajendra Karki et al. Cell Reports
- Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
- (2021) Daniel Westaby et al. Cancers
- Revisiting Immunotherapy: A Focus on Prostate Cancer
- (2020) Ha-Ram Cha et al. CANCER RESEARCH
- Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation
- (2020) Chao Liu et al. CLINICAL CANCER RESEARCH
- Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
- (2020) Min Zheng et al. CELL
- Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis
- (2020) Yi-Fan Tan et al. Cell Death & Disease
- Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
- (2020) Shelbi Christgen et al. Frontiers in Cellular and Infection Microbiology
- Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
- (2020) Rong Tang et al. Journal of Hematology & Oncology
- Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
- (2020) Chunxiao Li et al. Molecular Cancer
- Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
- (2020) David A. Siegel et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
- (2020) Rilan Bai et al. Biomarker Research
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- ZBTB24 regulates the apoptosis of human T cells via CDCA7/TRAIL-receptor axis
- (2019) Xiao-Yuan Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
- (2019) Margot de Looff et al. Frontiers in Immunology
- Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis
- (2019) Kim Newton et al. NATURE
- The role of pyroptosis in cancer: pro-cancer or pro-“host”?
- (2019) Xiaojing Xia et al. Cell Death & Disease
- Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
- (2019) Melanie Fritsch et al. NATURE
- ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)
- (2019) R. K. Subbarao Malireddi et al. Frontiers in Cellular and Infection Microbiology
- Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
- (2019) R.K. Subbarao Malireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis
- (2018) Delong Jiao et al. CELL RESEARCH
- Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma
- (2018) Ayano Kabashima et al. JOURNAL OF HEPATOLOGY
- Metastatic Prostate Cancer
- (2018) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
- (2018) Wassim Abida et al. JAMA Oncology
- Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
- (2017) Evangelos Giampazolias et al. NATURE CELL BIOLOGY
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
- (2016) Nieves Peltzer et al. TRENDS IN CELL BIOLOGY
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells
- (2015) N. Yatim et al. SCIENCE
- RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
- (2015) Susanne V. Schmidt et al. Oncotarget
- Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis
- (2015) Sean P. Cullen et al. Cell Reports
- Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
- (2014) Michael J. White et al. CELL
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
- (2013) Y Dondelinger et al. CELL DEATH AND DIFFERENTIATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Prostate cancer and inflammation: the evidence
- (2011) Karen S Sfanos et al. HISTOPATHOLOGY
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- RIP3 mediates the embryonic lethality of caspase-8-deficient mice
- (2011) William J. Kaiser et al. NATURE
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
- (2009) Kathleen Ebelt et al. EUROPEAN JOURNAL OF CANCER
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Apoptosis: controlled demolition at the cellular level
- (2007) Rebecca C. Taylor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now